生物补片与一期会阴关闭在直肠癌ELAPE术后5年随机对照结果
BIOPEX试验事后二次分析比较直肠癌经腹会阴联合切除(ELAPE)并术前放疗后生物补片会阴关闭(n=50,2例脱落)与一期会阴关闭(n=54,1例脱落)的5年结局。5年症状性会阴疝累积发生率生物补片组7%(95%CI 0-30)显著低于一期关闭组30%(95%CI 10-49),P=0.006;会阴疝修补、小肠梗阻再手术及生活质量、功能结局无显著差异。
要点
- 5年症状性会阴疝发生率生物补片组7%显著低于一期关闭组30%(P=0.006)
- 会阴疝择期修补生物补片组2%对一期关闭组13%,差异未达显著(P=0.062)
- 慢性会阴伤口问题、局部复发、总生存及生活质量主要领域无显著差异
核心结论
- 直肠癌ELAPE术后5年随访,生物补片会阴关闭的症状性会阴疝发生率显著低于一期会阴关闭。
- 生物补片关闭未改善生活质量或功能结局。
研究设计与样本
- BIOPEX随机对照试验的事后二次分析,患者随机分为生物补片会阴关闭组(n=50,2例脱落)或一期会阴关闭组(n=54,1例脱落)。
- 随访5年,采用Kaplan-Meier法计算累积概率。
主要发现
- 5年症状性会阴疝发生率:生物补片组7%(95%CI 0-30),一期关闭组30%(95%CI 10-49),P=0.006。
- 会阴疝择期修补:生物补片组1例(2%),一期关闭组7例(13%),P=0.062。
- 小肠梗阻再手术:生物补片组1/48(2%),一期关闭组5/53(9%),P=0.208。
- 慢性会阴伤口问题、局部复发、总生存及生活质量与功能结局主要领域无显著差异。
关键数值与推荐
- 5年症状性会阴疝累积发生率分别为生物补片组7%(95%CI 0-30)与一期关闭组30%(95%CI 10-49),P=0.006。
- 会阴疝择期修补率分别为2%(1例)与13%(7例),P=0.062。
- 小肠梗阻再手术率分别为1/48(2%)与5/53(9%),P=0.208。
临床怎么用
- 对直肠癌ELAPE并术前放疗患者,生物补片会阴关闭可降低5年症状性会阴疝发生率。
- 生物补片关闭不应以改善生活质量或功能结局为目的,需结合个体情况选择。
局限性
- 本文为BIOPEX试验的事后二次分析。
- 部分比较事件数少,相应P值未达显著,解释需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine long-term outcomes of a randomized trial (BIOPEX) comparing biological mesh and primary perineal closure in rectal cancer patients after extralevator abdominoperineal resection and preoperative radiotherapy, with a primary focus on symptomatic perineal hernia. SUMMARY BACKGROUND DATA: BIOPEX is the only randomized trial in this field, which was negative on its primary endpoint (30-day wound healing). METHODS: This was a posthoc secondary analysis of patients randomized in the BIOPEX trial to either biological mesh closure (n = 50; 2 dropouts) or primary perineal closure (n = 54; 1 dropout). Patients were followed for 5 years. Actuarial 5-year probabilities were determined by the Kaplan-Meier statistic. RESULTS: Actuarial 5-year symptomatic perineal hernia rates were 7% (95% CI, 0-30) after biological mesh closure versus 30% (95% CI, 10-49) after primary closure (P = 0.006). One patient (2%) in the biomesh group underwent elective perineal hernia repair, compared to 7 patients (13%) in the primary closure group (P = 0.062). Reoperations for small bowel obstruction were necessary in 1/48 patients (2%) and 5/53 patients (9%), respectively (P = 0.208). No significant differences were found for chronic perineal wound problems, locoregional recurrence, overall survival, and main domains of quality of life and functional outcome. CONCLUSIONS: Symptomatic perineal hernia rate at 5-year follow-up after abdominoperineal resection for rectal cancer was significantly lower after biological mesh closure. Biological mesh closure did not improve quality of life or functional outcomes.
引用
- Blok RD, Sharabiany S, Stoker J, et al. Cumulative 5-year Results of a Randomized Controlled Trial Comparing Biological Mesh With Primary Perineal Wound Closure After Extralevator Abdominoperineal Resection (BIOPEX-study). Ann Surg. 2022. PMID: 33534231. doi:10.1097/SLA.0000000000004763
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。